Candida carbonyl reductase and method for preparing (R)-lipoic acid precursor

US10294479B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10294479-B2
Application numberUS-201515307455-A
CountryUS
Kind codeB2
Filing dateMar 4, 2015
Priority dateMar 4, 2015
Publication dateMay 21, 2019
Grant dateMay 21, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed herein is Candida parapsilosis CGMCC 9630, the carbonyl reductase expressed by said strain and the encoding gene and amino acid sequence thereof, the recombinant expression vector and recombinant expression transformant containing said gene sequence, and use of whole cells of Candida parapsilosis , carbonyl reductase or corresponding recombinant transformant thereof as catalyst in catalyzing asymmetric reduction of prochiral carbonyl compounds, particularly reduction of 6-carbonyl-8-halogenocaprylate to prepare the synthetic precursor of (R)-α-lipoic acid, (R)-6-hydroxy-8-halogenocaprylate. In comparison to other methods of asymmetric reduction for preparing (R)-6-hydroxy-8-halogenocaprylate, the disclosure has advantages of high substrate concentration, mild reaction conditions, environmental friendship, high yield, and high optical purity of the product, and thus has good prospect in industrial production of (R)-α-α-lipoic acid.

First claim

Opening claim text (preview).

What claimed is: 1. A Candida parapsilosis with the deposit number CGMCC 9630, wherein the Candida parapsilosis recombinantly expresses a carbonyl reductase, wherein the amino acid sequence of the carbonyl reductase is as set forth in SEQ ID Nos. 2, 4 or 6. 2. A recombinant and isolated carbonyl reductase encoding gene, wherein the gene is: (1) a nucleotide sequence as set forth in SEQ ID Nos. 1, 3 or 5; (2) an encoding gene of a protein with an amino acid sequence as set forth in SEQ ID Nos. 2, 4 or 6. 3. A recombinant expression vector, wherein the vector comprises the gene according to claim 2 , and optionally an encoding gene of a glucose dehydrogenase, wherein the glucose dehydrogenase is as set forth in SEQ ID No. 14. 4. A recombinant expression transformant, wherein the transformant comprises the recombinant expression vector according to claim 3 . 5. A method of preparing a carbonyl reductase, wherein the method comprises a step of culturing the Candida parapsilosis according to claim 1 . 6. The method of claim 5 , further comprising catalyzing an asymmetric reduction reaction of prochiral carbonyl compounds using the carbonyl reductase as a catalyst in the reduction reaction in vitro. 7. The method according to claim 6 , wherein the concentration of the prochiral carbonyl compounds is 1 to 1500 mmol/L, and the amount of the carbonyl reductase is 8.0-800 U per mmol of prochiral carbonyl compounds. 8. The method according to claim 6 , wherein in the asymmetric reduction reaction, the following is further added: (1) 0 to 10 mmol/L of coenzyme NADPH; or (2) 0 to 340 U of glucose dehydrogenase per mmol of prochiral carbonyl compounds, 0 to 0.3 g of glucose per mmol of prochiral carbonyl compounds, and 0 to 1.0 mmol/L of NADP + . 9. The method according to claim 6 , wherein the prochiral carbonyl compounds are selected from the followings: wherein R 1 is selected from —CH 2 (CH 3 ) 2 , −2-Cl—C 6 H 4 and —(CH 2 ) 2 C 6 H 5 ; R 2 is —CH 3 or —CH 2 CH 3 ; R 3 is —CH 2 C 1 , —CH 2 CH 3 or —(CH 2 ) 2 CH 3 ; R 4 is —CH 3 or —CH 2 CH 3 . 10. The method according to claim 9 , wherein the prochiral carbonyl compound is ethyl 6-carbonyl-8-chlorocaprylate.

Assignees

Inventors

Classifications

  • Carbonyl reductase (NADPH) (1.1.1.184) · CPC title

  • acting on NADH or NADPH (1.6) · CPC title

  • for yeasts · CPC title

  • Chemistry & Metallurgy · mapped topic

  • Yeasts; Culture media therefor · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10294479B2 cover?
Disclosed herein is Candida parapsilosis CGMCC 9630, the carbonyl reductase expressed by said strain and the encoding gene and amino acid sequence thereof, the recombinant expression vector and recombinant expression transformant containing said gene sequence, and use of whole cells of Candida parapsilosis , carbonyl reductase or corresponding recombinant transformant thereof as catalyst in …
Who is the assignee on this patent?
Univ East China Science & Tech
What technology area does this patent fall under?
Primary CPC classification C12N15/52. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 21 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).